Skip to content

Clinical trials

Phase 1 Neoplasms, Glandular and Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms, Glandular and Epithelial Phase: Phase 1 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20141
20151
20162
20181
20191
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Revolution Medicines, Inc.2
Syndax Pharmaceuticals2
Advaxis, Inc.1
Arsenal Biosciences, Inc.1
DNAtrix, Inc.1
German Cancer Research Center1
M.D. Anderson Cancer Center1
Sesen Bio, Inc.1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms, Glandular and Epithelial11
Neoplasms9
Neoplasms by Histologic Type6
Digestive System Neoplasms5
Neoplasms by Site5
Bronchial Neoplasms4
Carcinoma, Non-Small-Cell Lung4
Lung Diseases4
Lung Neoplasms4
Respiratory Tract Neoplasms4

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.